https://stock.noler.com/us/stock/sage-therapeutics-inc https://stock.noler.com/us/stock/sage-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/sage-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/sage-therapeutics-inc/accounts-receivable-related-parties-current https://stock.noler.com/us/stock/sage-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/sage-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/sage-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/sage-therapeutics-inc/accumulated-depreciation-change https://stock.noler.com/us/stock/sage-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/sage-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/sage-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/sage-therapeutics-inc/amortization https://stock.noler.com/us/stock/sage-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/sage-therapeutics-inc/aoci https://stock.noler.com/us/stock/sage-therapeutics-inc/asset-impairment-charges https://stock.noler.com/us/stock/sage-therapeutics-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/sage-therapeutics-inc/available-for-sale-change-in-net-unrealized-holding-gain-loss-net-of-tax https://stock.noler.com/us/stock/sage-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/sage-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/sage-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/sage-therapeutics-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/sage-therapeutics-inc/available-for-sale-debt-unrealized-loss-position https://stock.noler.com/us/stock/sage-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer https://stock.noler.com/us/stock/sage-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-loss https://stock.noler.com/us/stock/sage-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-less-than-12-months https://stock.noler.com/us/stock/sage-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-less-than-12-months-loss https://stock.noler.com/us/stock/sage-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-loss https://stock.noler.com/us/stock/sage-therapeutics-inc/available-for-sale-in-unrealized-loss-positions-qualitative-disclosure-number-of-positions-less-than-one-year https://stock.noler.com/us/stock/sage-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/sage-therapeutics-inc/buybacks-treasury-shares-acquired https://stock.noler.com/us/stock/sage-therapeutics-inc/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/sage-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/sage-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/sage-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/sage-therapeutics-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/sage-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/sage-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/sage-therapeutics-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/sage-therapeutics-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/sage-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/sage-therapeutics-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/sage-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/sage-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/sage-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/sage-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/sage-therapeutics-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/sage-therapeutics-inc/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/sage-therapeutics-inc/cost-of-revenue https://stock.noler.com/us/stock/sage-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/sage-therapeutics-inc/current-assets https://stock.noler.com/us/stock/sage-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/sage-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-offering-costs https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-revenue-additions https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-tax-liabilities-current https://stock.noler.com/us/stock/sage-therapeutics-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/sage-therapeutics-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/sage-therapeutics-inc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/sage-therapeutics-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/sage-therapeutics-inc/depreciation https://stock.noler.com/us/stock/sage-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/sage-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/sage-therapeutics-inc/dividends-common-stock https://stock.noler.com/us/stock/sage-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/sage-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/sage-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/sage-therapeutics-inc/eps https://stock.noler.com/us/stock/sage-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/sage-therapeutics-inc/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/sage-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/sage-therapeutics-inc/foreign-pretax-income https://stock.noler.com/us/stock/sage-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/sage-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/sage-therapeutics-inc/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/sage-therapeutics-inc/income-tax https://stock.noler.com/us/stock/sage-therapeutics-inc/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/sage-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/sage-therapeutics-inc/increase-decrease-in-accounts-receivable-related-parties https://stock.noler.com/us/stock/sage-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/sage-therapeutics-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/sage-therapeutics-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/sage-therapeutics-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/sage-therapeutics-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/sage-therapeutics-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/sage-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/sage-therapeutics-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/sage-therapeutics-inc/incremental-common-shares-attributable-to-conversion-of-preferred-stock https://stock.noler.com/us/stock/sage-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/sage-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/sage-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/sage-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/sage-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/sage-therapeutics-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/sage-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/sage-therapeutics-inc/investment-income-amortization-of-premium https://stock.noler.com/us/stock/sage-therapeutics-inc/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/sage-therapeutics-inc/investments-fair-value-disclosure https://stock.noler.com/us/stock/sage-therapeutics-inc/lease-and-rental-expense https://stock.noler.com/us/stock/sage-therapeutics-inc/lease-cost https://stock.noler.com/us/stock/sage-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/sage-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/sage-therapeutics-inc/liability-for-uncertain-tax-positions-current https://stock.noler.com/us/stock/sage-therapeutics-inc/marketable-securities https://stock.noler.com/us/stock/sage-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/sage-therapeutics-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/sage-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/sage-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/sage-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/sage-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/sage-therapeutics-inc/net-income https://stock.noler.com/us/stock/sage-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/sage-therapeutics-inc/number-of-reportable-segments https://stock.noler.com/us/stock/sage-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/sage-therapeutics-inc/oci-net-of-tax https://stock.noler.com/us/stock/sage-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-income https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/sage-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/sage-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/sage-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/sage-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/sage-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/sage-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/sage-therapeutics-inc/other-receivables-net-current https://stock.noler.com/us/stock/sage-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/sage-therapeutics-inc/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/sage-therapeutics-inc/payments-for-restructuring https://stock.noler.com/us/stock/sage-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/sage-therapeutics-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/sage-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/sage-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/sage-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/sage-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/sage-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/sage-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/sage-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/sage-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/sage-therapeutics-inc/pretax-income-domestic https://stock.noler.com/us/stock/sage-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/sage-therapeutics-inc/proceeds-from-collaborators https://stock.noler.com/us/stock/sage-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/sage-therapeutics-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/sage-therapeutics-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/sage-therapeutics-inc/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/sage-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/sage-therapeutics-inc/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/sage-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/sage-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/sage-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/sage-therapeutics-inc/property-plant-and-equipment-gross-change https://stock.noler.com/us/stock/sage-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/sage-therapeutics-inc/public-float https://stock.noler.com/us/stock/sage-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/sage-therapeutics-inc/restricted-cash https://stock.noler.com/us/stock/sage-therapeutics-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/sage-therapeutics-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/sage-therapeutics-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/sage-therapeutics-inc/restructuring-and-related-cost-expected-cost-remaining https://stock.noler.com/us/stock/sage-therapeutics-inc/restructuring-and-related-cost-incurred-cost https://stock.noler.com/us/stock/sage-therapeutics-inc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/sage-therapeutics-inc/restructuring-charges https://stock.noler.com/us/stock/sage-therapeutics-inc/restructuring-costs https://stock.noler.com/us/stock/sage-therapeutics-inc/restructuring-reserve https://stock.noler.com/us/stock/sage-therapeutics-inc/restructuring-reserve-current https://stock.noler.com/us/stock/sage-therapeutics-inc/restructuring-reserve-settled-without-cash https://stock.noler.com/us/stock/sage-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/sage-therapeutics-inc/revenue https://stock.noler.com/us/stock/sage-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/sage-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/sage-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/sage-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/sage-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/sage-therapeutics-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/sage-therapeutics-inc/shares-issued-shares-espps https://stock.noler.com/us/stock/sage-therapeutics-inc/shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/sage-therapeutics-inc/short-term-lease-cost https://stock.noler.com/us/stock/sage-therapeutics-inc/state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-award-rsu-vested-in-period-total-fair-value https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/sage-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/sage-therapeutics-inc/sublease-income https://stock.noler.com/us/stock/sage-therapeutics-inc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/sage-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/sage-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sage-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/sage-therapeutics-inc/tax-rate-reconciliation-deductions-medicare-prescription-drug-benefit https://stock.noler.com/us/stock/sage-therapeutics-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/sage-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/sage-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/sage-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/sage-therapeutics-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/sage-therapeutics-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/sage-therapeutics-inc/temporary-equity-accretion-to-redemption-value https://stock.noler.com/us/stock/sage-therapeutics-inc/temporary-equity-accretion-to-redemption-value-adjustment https://stock.noler.com/us/stock/sage-therapeutics-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/sage-therapeutics-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/sage-therapeutics-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/sage-therapeutics-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/sage-therapeutics-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/sage-therapeutics-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/sage-therapeutics-inc/total-assets https://stock.noler.com/us/stock/sage-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/sage-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/sage-therapeutics-inc/treasury-stock-common-shares https://stock.noler.com/us/stock/sage-therapeutics-inc/treasury-stock-common-value https://stock.noler.com/us/stock/sage-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/sage-therapeutics-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/sage-therapeutics-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/sage-therapeutics-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/sage-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/sage-therapeutics-inc/variable-lease-cost https://stock.noler.com/us/stock/sage-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted